Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis
Endpoints
Thu, 03/9/17 - 11:34 am
Pfizer
Servier
FDA
CAR-T
UCART19
Cellectis
acute lymphocytic leukemia
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Motley Fool
Mon, 03/6/17 - 09:40 am
Juno Therapeutics
PTC Therapeutics
CAR-T
Celgene
cystic fibrosis
Translarna
Juno ends flagship drug trial after deaths and FDA suspensions
Bizjournals.com
Wed, 03/1/17 - 08:59 pm
Juno Therapeutics
clinical trials
FDA
JCAR015
CAR-T
acute lymphoblastic leukemia
Kite Pharma reports positive results from non-Hodgkins lymphoma drug study
Marketwatch
Tue, 02/28/17 - 11:08 am
Kite Pharma
non-Hodgkins lymphoma
KTE-C19
CAR-T
Novartis Out To Prove Its Oncology Doubters Wrong
Seeking Alpha
Sat, 01/28/17 - 02:22 pm
Novartis
oncology
CAR-T
Fighting a generic onslaught, Novartis adds CAR-T to its growing list of late-stage blockbusters
Endpoints
Wed, 01/25/17 - 09:55 am
Novartis
generics
CAR-T
Novartis chief Jimenez touts two top PhIII drug prospects
Endpoints
Wed, 01/18/17 - 10:07 am
Novartis
Joe Jimenez
CTL-019
BAF-312
CAR-T
progressive MS
multiple sclerosis
Kite Pharma partners with Japan's Daiichi for cancer therapy
Yahoo/Reuters
Tue, 01/10/17 - 11:11 am
Kite Pharma
Japan
Daiichi Sankyo
axicabtagene ciloleucel
CAR-T
Fortress Bio soars after reporting breakthrough with CAR-T cancer approach
Marketwatch
Thu, 12/29/16 - 10:22 am
Fortress Biotech
CAR-T
MB-101
brain cancer
CAR-T therapy makes early inroads in treating brain cancer
Stat
Wed, 12/28/16 - 07:35 pm
CAR-T
glioblastoma
brain cancer
Juno Therapeutics Defeats Kite Pharma’s Challenge to CAR T-Cell Patent
Yahoo
Mon, 12/19/16 - 11:41 am
Juno Therapeutics
Kite Pharma
CAR-T
patents
Novartis' Big News at ASH? It's Still in the CAR-T Race
Motley Fool
Fri, 12/16/16 - 11:28 am
Novartis
ASH
CAR-T
CTL-019
Kite, Juno Cancer Data Fuel Price Dip
Investopedia
Thu, 12/8/16 - 10:05 am
Kite Pharma
Juno Therapeutics
CAR-T
non-Hodgkins lymphoma
Novartis Makes Its Case For Driving A CAR Into The Real World
Seeking Alpha
Mon, 12/5/16 - 10:43 pm
Novartis
CAR-T
Kite Pharma
CTL019
KTE-C19
Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission
Endpoints
Mon, 12/5/16 - 10:01 am
Kite Pharma
CAR-T
clinical trials
KTE-C19
acute lymphoblastic leukemia
In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program
Endpoints
Sun, 12/4/16 - 12:24 pm
Novartis
CAR-T
CTL019
B-cell acute lymphoblastic leukemia
Juno and the FDA screwed up. People died. What now?
Endpoints
Mon, 11/28/16 - 09:47 am
Juno Therapeutics
CAR-T
JCAR015
FDA
clinical trials
Latest deaths in Juno trial underscore the need for greater transparency in clinical trials
Stat
Fri, 11/25/16 - 09:15 am
clinical trials
transparency
CAR-T
Juno Therapeutics
Juno Therapeutics plummets 30% in pre-market trade after two patient deaths
Marketwatch
Wed, 11/23/16 - 10:20 am
Juno Therapeutics
CAR-T
JCAR015
clinical trials
fludarabine
Kite Pharma to keep anticipated CAR-T launch 'controlled' and targeted at certain hospitals
Medical Marketing and Media
Wed, 11/16/16 - 09:59 am
Kite Pharma
CAR-T
KTE-C19
diffuse large B-cell lymphoma
Pages
« first
‹ previous
…
18
19
20
21
22
23
24
25
26
next ›
last »